Research ArticleReviews

Impact of Radiographic Bronchiectasis in COPD

Lei Shi, Fengxian Wei, Tiantian Ma, Weixin Zhou, Min Li and Yixin Wan
Respiratory Care October 2020, 65 (10) 1561-1573; DOI: https://doi.org/10.4187/respcare.07390

References

  1. 1.↵
    1. Singh D,
    2. Agusti A,
    3. Anzueto A,
    4. Barnes PJ,
    5. Bourbeau J,
    6. Celli BR,
    7. et al
    . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J 2019;53(5). pii: 1900164.
    OpenUrl
  2. 2.↵
    1. Chalmers JD
    . Bronchiectasis: phenotyping a complex disease. COPD 2017;14(suppl 1):S12-S18.
    OpenUrl
  3. 3.↵
    1. Flume PA,
    2. Chalmers JD,
    3. Olivier KN
    . Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet 2018;392(10150):880-890.
    OpenUrl
  4. 4.↵
    1. Wang K,
    2. Chen Y,
    3. Zhang P,
    4. Lin P,
    5. Xie N,
    6. Wu M
    . Protective features of autophagy in pulmonary infection and inflammatory diseases. Cells 2019;8(2). pii: E123
    OpenUrl
  5. 5.↵
    1. Ferreira IB,
    2. Lima EDNS,
    3. da Silva NC,
    4. Prestes IV,
    5. Pena GDG
    . Combination of red blood cell distribution width and body mass index (COR-BMI) predicts in-hospital mortality in patients with different diagnoses? PLoS One 2019;14(7):e0219549.
    OpenUrl
  6. 6.↵
    1. O’Donnell AE
    . Bronchiectasis in patients with COPD: a distinct COPD phenotype? Chest 2011;140(5):1107-1108.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Celli BR,
    2. Decramer M,
    3. Wedzicha JA,
    4. Wilson KC,
    5. Agusti AA,
    6. Criner GJ,
    7. et al
    ; ATS/ERS Task Force for COPD Research. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev 2015;24(136):159-172.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Koblizek V,
    2. Chlumsky J,
    3. Zindr V,
    4. Neumannova K,
    5. Zatloukal J,
    6. Zak J,
    7. et al
    ; Czech Pneumological and Phthisiological Society. Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013;157(2):189-201.
    OpenUrlPubMed
  9. 9.↵
    1. Ni Y,
    2. Shi G,
    3. Yu Y,
    4. Hao J,
    5. Chen T,
    6. Song H
    . Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2015;10:1465-1475.
    OpenUrlPubMed
  10. 10.↵
    1. Du Q,
    2. Jin J,
    3. Liu X,
    4. Sun Y
    . Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One 2016;11(3):e0150532.
    OpenUrl
  11. 11.↵
    1. Crisafulli E,
    2. Guerrero M,
    3. Ielpo A,
    4. Ceccato A,
    5. Huerta A,
    6. Gabarrús A,
    7. et al
    . Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a propensity matched analysis. Sci Rep 2018;8(1):9236.
    OpenUrl
  12. 12.↵
    1. Kawamatawong T,
    2. Onnipa J,
    3. Suwatanapongched T
    . Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Int J Chron Obstruct Pulmon Dis 2018;13:761-769.
    OpenUrl
  13. 13.↵
    1. Shamseer L,
    2. Moher D,
    3. Clarke M,
    4. Ghersi D,
    5. Liberati A,
    6. Petticrew M,
    7. et al
    ; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;350:g7647.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Naidich DP,
    2. McCauley DI,
    3. Khouri NF,
    4. Stitik FP,
    5. Siegelman SS
    . Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982;6(3):437-444.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Stang A
    . Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25(9):603-605.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Hozo SP,
    2. Djulbegovic B,
    3. Hozo I
    . Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Martínez-García MÁ,
    2. Soler-Cataluña JJ,
    3. Donat Sanz Y,
    4. Catalán Serra P,
    5. Agramunt Lerma M,
    6. Ballestín Vicente J,
    7. et al
    . Factors associated with bronchiectasis in patients with COPD. Chest 2011;140(5):1130-1137.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Bafadhel M,
    2. Umar I,
    3. Gupta S,
    4. Raj JV,
    5. Vara DD,
    6. Entwisle JJ,
    7. et al
    . The role of CT scanning in multidimensional phenotyping of COPD. Chest 2011;140(3):634-642.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Martínez-García MA,
    2. de la Rosa Carrillo D,
    3. Soler-Cataluña JJ,
    4. Donat-Sanz Y,
    5. Serra PC,
    6. Lerma MA,
    7. et al
    . Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(8):823-831.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Tulek B,
    2. Kivrak AS,
    3. Ozbek S,
    4. Kanat F,
    5. Suerdem M
    . Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J 2013;20(2):91-96.
    OpenUrl
  21. 21.↵
    1. Gatheral T,
    2. Kumar N,
    3. Sansom B,
    4. Lai D,
    5. Nair A,
    6. Vlahos I,
    7. Baker EH
    . COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD 2014;11(6):605-614.
    OpenUrlCrossRef
  22. 22.↵
    1. Ekici A,
    2. Bulcun E,
    3. Karakoc T,
    4. Senturk E,
    5. Ekici M
    . Factors associated with quality of life in subjects with stable COPD. Respir Care 2015;60(11):1585-1591.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Mao B,
    2. Lu HW,
    3. Li MH,
    4. Fan LC,
    5. Yang JW,
    6. Miao XY,
    7. Xu JF
    . The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep 2015;5:10961.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Jin J,
    2. Yu W,
    3. Li S,
    4. Lu L,
    5. Liu X,
    6. Sun Y
    . Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore) 2016;95(29):e4219.
    OpenUrl
  25. 25.↵
    1. Minov J,
    2. Stoleski S,
    3. Mijakoski D,
    4. Vasilevska K,
    5. Atanasovska A
    . Exacerbations in COPD patients with bronchiectasis. Med Sci (Basel) 2017;5(2). pii: E7.
    OpenUrl
  26. 26.↵
    1. Zhang RB,
    2. Yuan F,
    3. Tan XY,
    4. He QY
    . Evaluation of symptoms and risks in stable chronic obstructive pulmonary disease patients with radiographic bronchiectasis. Chronic Dis Transl Med 2017;3(3):176-180.
    OpenUrl
  27. 27.↵
    1. Bak SH,
    2. Kim S,
    3. Hong Y,
    4. Heo J,
    5. Lim MN,
    6. Kim WJ
    . Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis 2018;13:1421-1431.
    OpenUrl
  28. 28.↵
    1. Chung WS,
    2. Lin CL
    . Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: a population-based cohort study. Respir Med 2018;140:6-10.
    OpenUrl
  29. 29.↵
    1. Dou S,
    2. Zheng C,
    3. Cui L,
    4. Xie M,
    5. Wang W,
    6. Tian H,
    7. et al
    . High prevalence of bronchiectasis in emphysema-predominant COPD patients. Int J Chron Obstruct Pulmon Dis 2018;13:2041-2047.
    OpenUrl
  30. 30.↵
    1. Su VY-F,
    2. Perng D-W,
    3. Chou T-C,
    4. Chou Y-C,
    5. Chang Y-L,
    6. Hsu C-C,
    7. et al
    . Mucolytic agents and statins use is associated with a lower risk of acute exacerbations in patients with bronchiectasis-chronic obstructive pulmonary disease overlap. J Clin Med 2018;7(12):517.
    OpenUrl
  31. 31.↵
    1. Sánchez-Muñoz G,
    2. Lopez-de-Andrés A,
    3. Hernández-Barrera V,
    4. Jiménez-Garcia R,
    5. Pedraza-Serrano F,
    6. Puente-Maestu L,
    7. de Miguel Díez J
    . Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender. PLoS One 2019;14(1):e0211222.
    OpenUrl
  32. 32.↵
    1. Abd-Elazeem A,
    2. Sadek SH,
    3. Attia NM
    . COPD-bronchiectasis overlap syndrome: are there clinical, physiological and radiological synergistic effects? Egypt J Radiol Nucl Med 2018;49(1):23-28.
    OpenUrl
  33. 33.↵
    1. Elassal GMI,
    2. Raafat RH,
    3. Ahmed A
    . Study of bronchiectasis phenotype and the common pathogens involved in late COPD stages. Egypt J Chest Dis Tuberc 2018;67(3):221-225.
    OpenUrl
  34. 34.↵
    1. Pitassi M,
    2. Vitale C,
    3. D’Amato M,
    4. Stanziola A,
    5. Mormile M,
    6. Molino A
    . Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD. Eur Respir J 2015;46.
  35. 35.↵
    1. Chandrasekaran R,
    2. Mac Aogáin M,
    3. Chalmers JD,
    4. Elborn SJ,
    5. Chotirmall SH
    . Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med 2018;18(1):83.
    OpenUrl
  36. 36.↵
    1. Martinez-Garcia MA,
    2. Miravitlles M
    . Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis 2017;12:1401-1411.
    OpenUrlPubMed
  37. 37.↵
    1. Hurst JR,
    2. Elborn JS,
    3. De Soyza A
    ; BRONCH-UK Consortium. COPD-bronchiectasis overlap syndrome. Eur Respir J 2015;45(2):310-313.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Kim EK,
    2. Kim MA,
    3. Lee JH,
    4. Lee SM,
    5. Lee JS,
    6. Oh YM
    . The prognostic role of the bronchiectasis in patients with COPD. Eur Respir J 2017;50(suppl 61):PA3631.
    OpenUrl
  39. 39.↵
    1. Qi Q,
    2. Li T,
    3. Li JC,
    4. Li Y
    . Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. Braz J Med Biol Res 2015;48(8):715-724.
    OpenUrl
  40. 40.↵
    1. Celli BR,
    2. Cote CG,
    3. Marin JM,
    4. Casanova C,
    5. Montes de Oca M,
    6. Mendez RA,
    7. et al
    . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005-1012.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Donaldson GC,
    2. Seemungal TA,
    3. Bhowmik A,
    4. Wedzicha JA
    . Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57(10):847-852.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. De la Rosa D,
    2. Martínez-Garcia MA,
    3. Giron RM,
    4. Vendrell M,
    5. Olveira C,
    6. Borderias L,
    7. et al
    . Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry. PLoS One 2017;12(5):e0177931.
    OpenUrl
  43. 43.↵
    1. Garcia-Nuñez M,
    2. Marti S,
    3. Puig C,
    4. Perez-Brocal V,
    5. Millares L,
    6. Santos S,
    7. et al
    . Bronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa. Future Microbiol 2017;12:379-392.
    OpenUrl
  44. 44.↵
    1. Tufvesson E,
    2. Markstad H,
    3. Bozovic G,
    4. Ekberg M,
    5. Bjermer L
    . Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography. Int J Chron Obstruct Pulmon Dis 2017;12:3211-3219.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Murphy TF
    . The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis 2008;47(12):1534-1536.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Pasteur MC,
    2. Bilton D,
    3. Hill AT
    ; British Thoracic Society Non-CF Bronchiectasis Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65(7):577.
    OpenUrlFREE Full Text
  47. 47.↵
    1. Woodhead M,
    2. Blasi F,
    3. Ewig S,
    4. Garau J,
    5. Huchon G,
    6. Ieven M,
    7. et al
    ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections–summary. Clin Microbiol Infect 2011;17(Suppl 6):1-24.
    OpenUrlCrossRef
  48. 48.↵
    1. Millares L,
    2. Ferrari R,
    3. Gallego M,
    4. Garcia-Nuñez M,
    5. Pérez-Brocal V,
    6. Espasa M,
    7. et al
    . Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 2014;33(7):1101-1111.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Miravitlles M,
    2. Espinosa C,
    3. Fernández-Laso E,
    4. Martos JA,
    5. Maldonado JA,
    6. Gallego M
    . Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 1999;116(1):40-46.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    1. Cole PJ
    . Inflammation: a two-edged sword--the model of bronchiectasis. Eur Respir J Suppl 1986;147:6-15.
    OpenUrl
  51. 51.
    1. Lin SH,
    2. Ji BC,
    3. Shih YM,
    4. Chen CH,
    5. Chan PC,
    6. Chang YJ,
    7. et al
    . Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients. Int J Tuberc Lung Dis 2013;17(12):1638-1644.
    OpenUrl
  52. 52.↵
    1. Andréjak C,
    2. Nielsen R,
    3. Thomsen VØ,
    4. Duhaut P,
    5. Sørensen HT,
    6. Thomsen RW
    . Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 2013;68(3):256-262.
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    1. Chalmers JD
    . Bronchiectasis and COPD overlap: a case of mistaken identity? Chest 2017;151(6):1204-1206.
    OpenUrl
  54. 54.↵
    1. Tunney MM,
    2. Einarsson GG,
    3. Wei L,
    4. Drain M,
    5. Klem ER,
    6. Cardwell C,
    7. et al
    . Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013;187(10):1118-1126.
    OpenUrlCrossRefPubMedWeb of Science
  55. 55.↵
    1. Balkissoon R
    . Journal Club--bronchiectasis/COPD overlap: syndrome versus treatable trait? Chronic Obstr Pulm Dis 2019;6(2):193-199.
    OpenUrl
  56. 56.↵
    1. Curtis JL,
    2. Freeman CM,
    3. Hogg JC
    . The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 2007;4(7):512-521.
    OpenUrlCrossRefPubMed
  57. 57.↵
    1. Maglione M,
    2. Aksamit T,
    3. Santamaria F
    . Paediatric and adult bronchiectasis: specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel disease. Respirology 2019;24(11):1063-1072.
    OpenUrl
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords